PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$1.27+0.06 (+4.96%)

Close on Nov 13, 2026Market cap $67.89MP/E –Yield –

PMV Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

PMV Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?